
About Vector Biolabs
Vector Biolabs is a Healthcare company based in Philadelphia (United States) founded in 2004. It offers custom gene delivery solutions through AAV and Adenovirus for scientific research. It operates on a B2B and Direct Sales model. Vector Biolabs offers products and services including Custom AAV Production, Adenovirus Services, AAV Products, and Adenovirus Products. Its focus areas include Life Sciences, Biotechnology, Research Tools and Gene Expression Products. Its legal entity is Vector Biosystems, Inc. Similar companies include Avidity Biosciences, Sutro Biopharma and Antheia; 3 of its 3 listed similar companies have raised funding.
Company details
Vector Biolabs specializes in providing custom services for recombinant AAV and Adenovirus, including vector design, cloning, packaging, and purification. They offer an extensive catalog of viral products for gene expression and therapy needs. Based in Malvern, PA, USA, they serve researchers and institutions requiring high-quality gene delivery tools for various applications.
- Headquarters Philadelphia, United States
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website vectorbiolabs.com
- Legal Name Vector Biosystems, Inc.
Products & Services of Vector Biolabs
Vector Biolabs offers a comprehensive portfolio of products and services, including Custom AAV Production, Adenovirus Services, AAV Products, and Adenovirus Products.
Service for designing and producing AAV vectors for research applications.
Custom services for adenovirus vector production and amplification.
Pre-made AAV products for gene expression and research needs.
Ready-to-use adenovirus for scientific and therapeutic applications.
People of Vector Biolabs
1 people are tracked at Vector Biolabs (1 in leadership).
| Name | Role | Group |
|---|---|---|
Jeffrey Edwards | CEO | Leadership |
Complete people profiles for Vector Biolabs
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Similar companies to Vector Biolabs
Vector Biolabs has 3 listed similar companies in our database, 3 of them funded. They include Avidity Biosciences, Sutro Biopharma and Antheia.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| aviditybiosciences.com | 2012 | San Diego, United States | $142.54M | 253 | Antibody-siRNA complexes are developed for cancer treatment. | |
| sutrobio.com | 2003 | United States | $171.85M | 235 | Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | |
| antheia.bio | 2013 | Palo Alto, United States | $152.37M | 50 | Yeast cells are genetically engineered to produce medicinal products. |
Detailed similar companies of Vector Biolabs
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Vector Biolabs
Websites that share an audience with Vector Biolabs (vectorbiolabs.com).
Websites whose visitors overlap most with Vector Biolabs. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| amsbio.com | 93% | 59.3K | #613,920 | View details | |
| vectorbuilder.com | 90% | 127.2K | View details | ||
| genecopoeia.com | 75% | 17.2K | #1,512,108 | View details | |
| vectorlabs.com | 63% | 65.9K | #500,436 | View details |
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Vector Biolabs (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Vector Biolabs
Vector Biolabs was founded in 2004.
Vector Biolabs is headquartered in Philadelphia, United States. It is registered at Philadelphia, Pennsylvania, United States.
Vector Biolabs specializes in providing custom services for recombinant AAV and Adenovirus, including vector design, cloning, packaging, and purification. They offer an extensive catalog of viral products for gene expression and therapy needs. Based in Malvern, PA, USA, they serve researchers and institutions requiring high-quality gene delivery tools for various applications.
Vector Biolabs's top competitors include Sutro Biopharma, Avidity Biosciences and Antheia.
Vector Biolabs offers Custom AAV Production, Adenovirus Services, AAV Products, and Adenovirus Products.
Vector Biolabs operates through Vector Biosystems, Inc..